AZD7442 Reduced Risk of Developing Severe COVID-19 or Death in TACKLE Phase III Outpatient Treatment Trial
This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
Dr. Koffman on COVID-19 Vaccines
12/2020
There is promising news about COVID-19 vaccines, but does that news apply to those of us with CLL? The Moderna and Pfizer vaccines are made with a new technology that uses messenger or mRNA that teaches our cells to recognize SARS-CoV-2’s spike protein and thus prevent infection. The live Oxford/AstraZeneca vaccine is also a new type of vaccine, made from a virus that causes colds in chimpanzees and has been genetically modified not to replicate in humans and to carry into our immune cells the SARS-CoV-2’s spike protein that confers immunity. Dr. Koffman shares what we know, what we don’t know and next steps.
Related posts
